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FINAL EXAMINATION DURATION 
PHA411 – Therapeutics C 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
Section A: Answer all 100 questions – 1 mark each = 100 marks  - Allocated time 100 minutes 
Section B: Short Answers Case Studies - Answer all THREE questions – 100 marks - Allocated 
time 80 minutes 
EXAM CONDITIONS 
 
You may begin writing from the commencement of the examination session.  The reading time 
indicated above is provided as a guide only. 
This is a RESTRICTED OPEN BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
Any hard copy, unannotated English dictionary is permitted 
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1 x 8 Page Book 
1 x 20 Page Book 
1 x 5-Multiple Choice Answer Sheet 
1 x Scrap Paper 
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Part A – Answer all 100 questions – 1 mark each = 100 marks - Allocated 
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Part B – Short Answers Case Studies 
Answer all THREE questions – Allocated time 80 minutes 
 
1. Mr. Smith, a 46 year old man complains of shortness of breath on exertion, loss in weight 
(6.4kg) and increasing tiredness since the past 4 months. He notes fullness in his left upper 
quadrant and early satiety. He is married and lives with his wife of 25 years, is employed as 
a manager. He has a history of smoking for past 20 years, quit completely since 4 years, 
denies alcohol use.  On examination, lymphadenopathy is noted in right inguinal area- 
approx. 1cm, non-tender palpable node. Bone marrow biopsy reveals positive for 
Philadelphia chromosome. Marrow is hypercellular, 2-3% myeloblasts. There is no history 
of cancer in his family. He is diagnosed as Chronic myelocytic leukaemia - chronic phase. 
A. Describe the natural progression of CML                                                           
B. What is Philadelphia chromosome?                                                                       
C. Suggest an optimal treatment plan for this patient as well as the monitoring parameters. 
Would stem cell therapy be a viable option for this patient? Briefly explain what this 
treatment entails?                                                                                                  
 
(10+5+15 = 30 Marks, maximum of two pages = 1000 words) 
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Age 75 years and 3 months  
Sex Male 
Marital Status Married 
Allergies Amoxil causes angioedema  
Smoking Status Non Smoker 
Alcohol Dinks once fortnight 
Weight 89kgs 
Height 159cms 
Carer Details  XX– Patient’s wife  
Treating Doctor  Dr.  XX– Attending Physician  
Pharmacy Griffith Pharmacy 
 
Medical Conditions: prostatic cancer with bone metastasis, long term of IDC for several years 
with several episodes of urinary sepsis, IDC removed one month ago, voiding with difficulty 
since IDC removal, hematuria and dysuria, no clots.  
 
Medical History: type two diabetes mellitus, ischaemic heart disease, acute myocardial 
infarction, stent, hypertension, hypercholesterolaemia, osteoarthritis, recurrent UTIs, THR, 
HOCM. Current Condition: Patient admitted into hospital with urinary sepsis, fever, hematuria 
and dysuria.   
 
Medications History 






1 tab daily Current 
Micardis 80mg 1 tab daily Current 
Atorvastatin (APO) 20mg 1 tab mane Current 
Panadol Osteo 665mg  2 tab three times a day  Current 
Metoprolol (GENRX) 50 1 tab twice a day Current 
Metformin (APO) 1000mg Take 1 tab twice daily immediately after 
food   
Current 





Take one capsule three times a day Current 
Amlodipine 5mg Take 1 tab daily Current 
Omeprazole (APO) 20mg 1 tab at night Current 
Oxybutynin (Sandoz) 5mg  1 tab TDS PRN Current  
Isosorbide Mononitrate Swallow whole half a tablet in the 
morning 
Current 
Novomix 30 Flexpen INJ 
10 
44 units twice daily  Current 
Cardio Aspirin EC 100mg Take 1 tab in the morning Current 
Alprim 300mg Take 1 tab at night  Ceased  
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He was recently diagnosed with stage III SCLC. 
 
A. What is the treatment for his first complaint (voiding with difficulty)? 
B. What is the recommended regime for SCLC? 
C. If he moves to palliative what treatment will be required? Justify your answer. 
 
(10+10+20 = 40 Marks, maximum of two pages = 1000 words) 
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Case 3 
BP, a 55-year-old female underwent extensive abdominal surgery for carcinoma of the colon 
and rectum. Post-operatively, she was prescribed heparin 5000 units SC bd and a morphine 
infusion (1-3 mg/hour). Eight days post-operatively, BP was able to mobilise well and the 
heparin was discontinued. By this time her prescribed analgesia was paracetamol and/or 
diclofenac when required. Two days later, BP became acutely short of breath and developed 
right sided posterior subscapular pleuritic chest pain which was worse on coughing and deep 
breathing. A pulmonary embolus was suspected and she underwent a ventilation and perfusion 
scan which showed a mismatch in her right lung. 
BP was started on heparin 5000 units stat followed by an infusion of 24,000 - 40,000 units per 
day adjusted to keep her APTT within the range of 60-80 seconds. She is also taking treatment 
for menopause (Hormonal replacement therapy), blood pressure and arthritis. She has stoma for 
feeding and another for toileting. Five days into this treatment BP developed a generalised 
petechial rash. She was later diagnosed with metastatic brain and bone cancers. 
 
What the cause of the rash might be, and why now if she was not originally allergic to it? 
What is the treatment for brain cancer, and why? 
What should her medication be after the last diagnosis? 
 
(10+10+10 = 30 Marks, maximum of two pages = 1000 words) 
 
 
 
 
 
 
 
 
 
 
